MS
Murali Shripathy Harishchandra
About Murali Shripathy Harishchandra
Data last updated:
Murali Shripathy Harishchandra is a Director at Pentavalent Bio Sciences Private Limited (since 2015). The company operates in Pharma. Pentavalent Bio Sciences Private Limited reported revenue of ₹2.01 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Dec 2015 | 2015 | ₹2.01 Cr (FY 2023) | Active |
Board colleagues of Murali Shripathy Harishchandra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Soumya Paul | 07070580 | Pentavalent Bio Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Murali Shripathy Harishchandra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Murali Shripathy Harishchandra
Murali Shripathy Harishchandra currently holds 1 directorship: Pentavalent Bio Sciences Private Limited (Director, since 04 Dec 2015, revenue ₹2.01 Cr (FY 2023)).
Murali Shripathy Harishchandra was first appointed on 04 Dec 2015 as Director at Pentavalent Bio Sciences Private Limited.
The current boards of Murali Shripathy Harishchandra's companies include Soumya Paul (Pentavalent Bio Sciences Private Limited).